Quarterly report pursuant to Section 13 or 15(d)

Revenue from Contracts with Customers (Tables)

v3.22.1
Revenue from Contracts with Customers (Tables)
6 Months Ended
Mar. 31, 2022
Revenue from Contracts with Customers [Abstract]  
Revenue from Customers by Products

Three Months Ended

Six Months Ended

March 31,

March 31,

2022

2021

2022

2021

FC2

U.S. prescription channel

$

11,590,466

$

10,312,742

$

23,164,732

$

19,414,481

Global public health sector

1,437,928

3,027,745

3,998,794

7,680,164

Total FC2

13,028,394

13,340,487

27,163,526

27,094,645

PREBOOST®

862,831

Net revenues

$

13,028,394

$

13,340,487

$

27,163,526

$

27,957,476

Revenue by Geographic Area

Three Months Ended

Six Months Ended

March 31,

March 31,

2022

2021

2022

2021

United States

$

11,846,960

$

10,612,998

$

23,755,485

$

20,968,836

Other

1,181,434

2,727,489

3,408,041

6,988,640

Net revenues

$

13,028,394

$

13,340,487

$

27,163,526

$

27,957,476